海尔生物(688139)每日收评(06-19)

Group 1 - The stock of Haier Biomedical (688139) has a comprehensive score of 42.72, indicating a weak performance [1] - The main cost analysis shows that the current main cost is 30.07 CNY, with a 5-day main cost of 30.55 CNY and a 20-day main cost of 31.69 CNY [1] - There have been no instances of the stock hitting the upper limit in the past year, and it has also not hit the lower limit [1] Group 2 - The short-term pressure level is at 31.36 CNY, while the short-term support level is at 30.28 CNY [2] - The stock price has broken below the short-term support level, suggesting a cautious approach in the short term [2] - The MACD indicator has formed a golden cross signal, indicating potential upward momentum for certain stocks [3]